# ╭────────────────────────────────────────────────────────────────────────────────────────────────╮
# │  ACTION REQUIRED: REVIEW AND EDIT THIS FILE TO ENSURE IT ACCURATELY REFLECTS YOUR PROJECT!     │
# │                                                                                                │
# │  This file was generated from your existing project files and will be used for SUSHI           │
# │  configuration from now on. You may delete your package.json as it is no longer needed.        │
# ╰────────────────────────────────────────────────────────────────────────────────────────────────╯

# ╭──────────────────────────────ImplementationGuide-gh.json───────────────────────────────╮
# │  The properties below are used to create the ImplementationGuide resource. For a list of       │
# │  supported properties, see:                                                                    │
# │  http://build.fhir.org/ig/HL7/fhir-shorthand/branches/beta/sushi.html#ig-development           │
# ╰────────────────────────────────────────────────────────────────────────────────────────────────╯
id: hl7.eu.fhir.gh
canonical: http://hl7.eu/fhir/ig/gravitate-health
version: 0.1.0
name: GhImplementationGuide
title: Gravitate Health FHIR Implementation Guide
status: active
publisher: Gravitate Health Project
contact:
  - name: Gravitate Health Project
    telecom:
      - system: url
        value: https://www.gravitatehealth.eu/
description: Gravitate Health is an EU project aiming to empower and equip Europeans with health information for active personal health management and adherence to treatment.
license: CC0-1.0
fhirVersion: 5.0.0-snapshot1
#dependencies:
#  hl7.fhir.uv.ips: current
parameters:
  show-inherited-invariants: false
  path-resource: !!seq
  - input/resources/irbesartan
  - input/resources/oxymetazoline-hydrochloride
  - input/resources/dimethyl-fumarate
  autoload-resources: true
copyrightYear: 2021+
releaseLabel: CI Build

# resources:
  
    
    
#   Bundle/36773c03-3040-45e2-82c2-bc3fc968b6a6:
#     name: Irbesartan PIL (Greek)
#     description: Example of Greek Product information leaflet for Irbesartan    
#     exampleBoolean: true
#   Bundle/910d1748-674b-430c-b4ab-3665b266a31f:
#     name: Irbesartan PIL (English)
#     description: Example of English Product information leaflet for Irbesartan   
#     exampleBoolean: true
#   Bundle/995d3971-b899-43bf-857d-98c26634796d:
#     name: Irbesartan PIL (Norwegian)
#     description: Example of Norwegian Product information leaflet for Irbesartan   
#     exampleBoolean: true
    
#   Bundle/8f7eede7-0aac-41ca-8552-8f1f1c059e6a:
#     name: Oxymetazoline-hydrochloride  PIL (Greek)
#     description: Example of Greek Product information leaflet for Oxymetazoline-hydrochloride    
#     exampleBoolean: true
#   Bundle/69b66755-94ef-4ff6-a794-43a74e16ff00:
#     name: Oxymetazoline-hydrochloride PIL (English)
#     description: Example of English Product information leaflet for Oxymetazoline-hydrochloride   
#     exampleBoolean: true
#   Bundle/d1a125cf-b46c-40cf-82cf-5b754eb0f19e:
#     name: Oxymetazoline-hydrochloride PIL (Norwegian)
#     description: Example of Norwegian Product information leaflet for Oxymetazoline-hydrochloride   
#     exampleBoolean: true

# ╭────────────────────────────────────────────menu.xml────────────────────────────────────────────╮
# │  To use a provided input/includes/menu.xml file, delete the "menu" property below.             │
# ╰────────────────────────────────────────────────────────────────────────────────────────────────╯

pages:
  index.md:
    title: Introduction   
  02-core-epi-profile.md:
    title: Core ePI Profile
  03-terminology.md:
      title: Terminology
  04-Steps-to-create-Core-FHIR-ePI.md:
      title: Steps to create a Core FHIR ePI
  05-capability.md:
      title: Capability
  06-general-technical-conformance-requirements.md:
      title: General Technical Conformance Requirements
  07-Appendix.md:
      title: Appendix
  08-Annex-I-ema-fhir-epi-profile.md:
      title: Annex I - EU/EMA FHIR ePI Profile
  08-Annex-II-fda-fhir-epi-profile.md:
      title: Annex II - US/FDA FHIR ePI Profile
  08-Annex-III-pmda-fhir-epi-profile.md:
      title: Annex III - Japan/PMDA FHIR ePI Profile

			
menu:
  Table of Contents: toc.html
  Introduction: index.html
  Core ePI Profile: 02-core-epi-profile.html
  Terminology: 03-terminology.html
  Create ePI: 04-Steps-to-create-Core-FHIR-ePI.html
  Capability: 05-capability.html
  Technical Requirements: 06-general-technical-conformance-requirements.html    
  Artifact Index: artifacts.html
  Appendix: 07-Appendix.html
  Annexes:
    EU/EMA FHIR ePI Profile: 08-Annex-I-ema-fhir-epi-profile.html
    US/FDA FHIR ePI Profile: 08-Annex-II-fda-fhir-epi-profile.html
    Japan/PMDA FHIR ePI Profile: 08-Annex-III-pmda-fhir-epi-profile.html


# --- original 
# menu:
#   Introduction: index.html
#   Table of Contents: toc.html
#   Contextual information:
#     Connections: connections.html
#     ePI structure: ePI-structure.html
#     Use Case: use-case-example.html
#   Artifact Index: artifacts.html
#   Support:
#     FHIR Spec: http://hl7.org/fhir/R4/index.html
#     Downloads: downloads.html
#   Copyright: copyright.html

#  Capability Statements:
#    SmPC / PL: CapabilityStatement-capability-statement-ema.html


FSHOnly: false
